Hui Shao
Direktor/Vorstandsmitglied bei Hangzhou Adlai Nortye Biopharma Co. Ltd.
Profil
Hui Shao currently works at Hangzhou Adlai Nortye Biopharma Co. Ltd., as Non-Executive Director from 2020 and Adlai Nortye USA, Inc., as Director from 2020.
Mr. Shao also formerly worked at Adlai Nortye Ltd., as Non-Executive Director.
Mr. Shao received his undergraduate degree in 1993 from Northeast Normal University.
Aktive Positionen von Hui Shao
| Unternehmen | Position | Beginn |
|---|---|---|
Hangzhou Adlai Nortye Biopharma Co. Ltd.
 Hangzhou Adlai Nortye Biopharma Co. Ltd. BiotechnologyHealth Technology Part of Adlai Nortye Ltd., Hangzhou Adlai Nortye Biopharma Co. Ltd. is a clinical-stage biopharmaceutical company based in Hangzhou, China. Adlai Nortye is developing differentiated, innovative immuno-oncology medicines with a focus on discovering and developing important new treatments for cancer. The Chinese company's mission is to improve patient lives by identifying and developing differentiated innovative medicines that help people live better and longer. The company was founded in 2004 by Yang Lu, Dong Hui Yang, and Yang Lu has been the CEO since then. | Direktor/Vorstandsmitglied | 01.02.2020 |
| Adlai Nortye USA, Inc. | Direktor/Vorstandsmitglied | 01.01.2020 |
Ehemalige bekannte Positionen von Hui Shao
| Unternehmen | Position | Ende |
|---|---|---|
| ADLAI NORTYE LTD. | Direktor/Vorstandsmitglied | - |
Ausbildung von Hui Shao
| Northeast Normal University | Undergraduate Degree |
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
Beziehungen ersten Grades
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
| Börsennotierte Unternehmen | 1 |
|---|---|
| ADLAI NORTYE LTD. | Commercial Services |
| Private Unternehmen | 2 |
|---|---|
Hangzhou Adlai Nortye Biopharma Co. Ltd.
Hangzhou Adlai Nortye Biopharma Co. Ltd. BiotechnologyHealth Technology Part of Adlai Nortye Ltd., Hangzhou Adlai Nortye Biopharma Co. Ltd. is a clinical-stage biopharmaceutical company based in Hangzhou, China. Adlai Nortye is developing differentiated, innovative immuno-oncology medicines with a focus on discovering and developing important new treatments for cancer. The Chinese company's mission is to improve patient lives by identifying and developing differentiated innovative medicines that help people live better and longer. The company was founded in 2004 by Yang Lu, Dong Hui Yang, and Yang Lu has been the CEO since then. | Health Technology |
| Adlai Nortye USA, Inc. |
